Sveriges mest populära poddar
Blood Podcast
Blood Podcast

Single-cell genotyping of MDS/CMML clonal output, VTE risk in diffuse glioma, and Del(1p32) is an adverse prognostic factor in myeloma

21 min•16 mars 2023

Om avsnittet

In this week’s episode we’ll discuss how azacytidine therapy influences the contributions of mutated HSC clones to hematopoiesis in MDS and CMML, learn more about the risk of venous thromboembolism in patients with adult-type diffuse glioma, and discuss the importance of 1p32 deletions as an independent and adverse prognostic factor in myeloma.

Fler avsnitt

Visa alla avsnitt av Blood Podcast

Designing Durable Remissions in Relapsed AML and Follicular Lymphoma

16 min

Dose Makes the Cure: Venetoclax in Ph- ALL

14 min

Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome

30 min

MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

25 min

Predictive Markers of Glofitamab Resistance in R/R B-NHL

16 min

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

26 min

Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

15 min

Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

33 min

HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT

17 min

FLT3-ITD microclones in AML and Results from the RESET-PV trial

14 min

Blood Podcast med American Society of Hematology finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.